ARUP Achieves Reaccreditation Under College of American Pathologists ISO 15189 Program
Study will begin enrollment in Q1 2026 in the US and UK and leverage the BIOFIRE® SPOTFIRE® point-of-care diagnostics platform at U.S. sites.
Owlet’s new release creates the ultimate baby monitoring system for video, sleep, and medical-grade health tracking.
BioUtah Member Appreciation BBQ 2025 Recap
Kimbell & Associates: Trump Administration Issues MAHA Strategy Report of Recommendations to President Trump
If approved, ZORYVE cream would be the first and only topical PDE4 inhibitor indicated for plaque psoriasis in children as young as 2.
Salt Lake City Angels Invests in Freyya
The wearable baby monitor trusted by millions globally expands reach to three continents, including North America, Europe, and now Africa.
Dr. Gordon Ringold to advise on various strategies related to the development of the Company’s novel cancer treatment platform
BD Expands Peripheral Artery Disease Awareness Efforts with ‘Love Your Limbs’ Community Screening Initiative
Renowned leaders in neurology, movement disorders, and commercialization join to shape Celeste® market strategy
Generic Saxenda® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the U.S. market.